News

The new pill, called AD109, is a combination of atomoxetine and aroxybutynin, two drugs that tell your brain to keep the ...
A retrospective study shows sleep apnea can increase the risk for retinal vein occlusion in both men and women and is ...
Apnimed has scored another phase 3 knockout. The Massachusetts biotech’s daily pill for obstructive sleep apnea reduced the ...
The possibility of a dementia diagnosis may have a new origin, according to a recent study from UC Irvine. Medical research ...
This can lead to delays in diagnosis as sleep apnea in women can be mistaken for anxiety, depression and menopause. As the ...
RingConn, a leading smart ring innovator, has officially launched its flagship Gen 2 Smart Ring and accessories on ...
Most associate sleep apnea with snoring, but it’s the sound of silence doctors say patients should be concerned with.
Dream Sleep Apnea Therapeutics in Hermitage has a new name along with some brand-new services. “Our name will be called Dream ...
Apnimed Inc.’s lead oral therapy for obstructive sleep apnea has delivered a second round of positive phase III data, bringing a potential U.S. FDA filing closer. Top-line results taken from the ...
In addition to providing oral appliances, Legacy Dental is committed to educating patients about the importance of sleep ...